Friess, Helmut

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 30.

Moser, Elisa; Ura, Ayako; Vogel, Loreen; Steiger, Katja; Mogler, Carolin; Evert, Matthias; Märkl, Bruno; Scheidhauer, Klemens; Martignoni, Marc; Friess, Helmut; von Werder, Alexander; Marinoni, Ilaria; Perren, Aurel; Klöppel, Günter; Kasajima, Atsuko (2024). ARX, PDX1, ISL1 and CDX2 expression distinguishes five subgroups of PanNETs with correlations to histology, hormone expression and outcome. (In Press). Modern pathology, 37(11), p. 100595. Elsevier 10.1016/j.modpat.2024.100595

Perinel, Julie; Nappo, Gennaro; Zerbi, Alessandro; Heidsma, Charlotte M; Nieveen van Dijkum, Elisabeth J M; Han, Ho Seong; Yoon, Yoo-Seok; Satoi, Sohei; Demir, Ihsan Ekin; Friess, Helmut; Vashist, Yogesh; Izbicki, Jakob; Muller, Alexandra Charlotte; Gloor, Beat; Sandini, Marta; Gianotti, Luca; Subtil, Fabien; Adham, Mustapha (2022). Sporadic nonfunctional pancreatic neuroendocrine tumors: Risk of lymph node metastases and aggressiveness according to tumor size: A multicenter international study. Surgery, 172(3), pp. 975-981. Elsevier 10.1016/j.surg.2022.04.013

Marr, Lisa; Haller, Bernhard; Pyka, Thomas; Peeken, Jan C; Jesinghaus, Moritz; Scheidhauer, Klemens; Friess, Helmut; Combs, Stephanie E; Münch, Stefan (2022). Predictive value of clinical and 18F-FDG-PET/CT derived imaging parameters in patients undergoing neoadjuvant chemoradiation for esophageal squamous cell carcinoma. Scientific reports, 12(1), p. 7148. Springer Nature 10.1038/s41598-022-11076-0

Beyer, Georg; Hoffmeister, Albrecht; Michl, Patrick; Gress, Thomas Mathias; Huber, Wolfgang; Algül, Hana; Neesse, Albrecht; Meining, Alexander; Seufferlein, Thomas W; Rosendahl, Jonas; Kahl, Stefan; Keller, Jutta; Werner, Jens; Friess, Helmut; Bufler, Philip; Löhr, Matthias J; Schneider, Alexander; Lynen Jansen, Petra; Esposito, Irene; Grenacher, Lars; ... (2022). S3-Leitlinie Pankreatitis – Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS)1. Zeitschrift für Gastroenterologie, 60(3), pp. 419-521. Thieme 10.1055/a-1735-3864

Reim, Daniel; Novotny, Alexander; Friess, Helmut; Slotta-Huspenina, Julia; Weichert, Wilko; Ott, Katja; Dislich, Bastian; Lorenzen, Sylvie; Becker, Karen; Langer, Rupert (2020). Significance of tumour regression in lymph node metastases of gastric and gastro-oesophageal junction adenocarcinomas. The journal of pathology: clinical research, 6(4), pp. 263-272. Wiley 10.1002/cjp2.169

Kaufmann, Benedikt; Hartmann, Daniel; D'Haese, Jan G; Stupakov, Pavel; Radenkovic, Dejan; Gloor, Beat; Friess, Helmut (2019). Neoadjuvant Treatment for Borderline Resectable Pancreatic Ductal Adenocarcinoma. Digestive surgery, 36(6), pp. 455-461. Karger 10.1159/000493466

Liebl, Florian; Demir, Ihsan Ekin; Mayer, Katharina; Schuster, Tibor; DʼHaese, Jan G; Becker, Karen; Langer, Rupert; Bergmann, Frank; Wang, Kun; Rosenberg, Robert; Novotny, Alexander R; Feith, Marcus; Reim, Daniel; Friess, Helmut; Ceyhan, Güralp O (2014). The impact of neural invasion severity in gastrointestinal malignancies: a clinicopathological study. Annals of surgery, 260(5), pp. 900-907. Lippincott Williams & Wilkins 10.1097/SLA.0000000000000968

Reim, Daniel; Loos, Martin; Vogl, Fabian; Novotny, Alexander; Schuster, Tibor; Langer, Rupert; Becker, Karen; Höfler, Heinz; Siveke, Jens; Bassermann, Florian; Friess, Helmut; Schuhmacher, Christoph (2013). Prognostic implications of the seventh edition of the international union against cancer classification for patients with gastric cancer: the Western experience of patients treated in a single-center European institution. Journal of clinical oncology, 31(2), pp. 263-271. American Society of Clinical Oncology 10.1200/JCO.2012.44.4315

Liebl, Florian; Demir, Ihsan Ekin; Rosenberg, Robert; Boldis, Alexandra; Yildiz, Esra; Kujundzic, Kristina; Kehl, Timo; Dischl, Dominic; Schuster, Tibor; Maak, Matthias; Becker, Karen; Langer, Rupert; Laschinger, Melanie; Friess, Helmut; Ceyhan, Güralp O. (2013). The severity of neural invasion is associated with shortened survival in colon cancer. Clinical cancer research, 19(1), pp. 50-61. American Association for Cancer Research 10.1158/1078-0432.CCR-12-2392

Becker, Karen; Reim, Daniel; Novotny, Alexander; Zum Büschenfelde, Christian Meyer; Engel, Jutta; Friess, Helmut; Höfler, Heinz; Langer, Rupert (2012). Proposal for a multifactorial prognostic score that accurately classifies 3 groups of gastric carcinoma patients with different outcomes after neoadjuvant chemotherapy and surgery. Annals of surgery, 256(6), pp. 1002-7. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/SLA.0b013e318262a591

Meding, Stephan; Balluff, Benjamin; Elsner, Mareike; Schöne, Cédrik; Rauser, Sandra; Nitsche, Ulrich; Maak, Matthias; Schäfer, Alexander; Hauck, Stefanie M; Ueffing, Marius; Langer, Rupert; Höfler, Heinz; Friess, Helmut; Rosenberg, Robert; Walch, Axel (2012). Tissue-based proteomics reveals FXYD3, S100A11 and GSTM3 as novel markers for regional lymph node metastasis in colon cancer. Journal of pathology, 228(4), pp. 459-470. Chichester: Wiley 10.1002/path.4021

Meding, Stephan; Nitsche, Ulrich; Balluff, Benjamin; Elsner, Mareike; Rauser, Sandra; Schöne, Cédrik; Nipp, Martin; Maak, Matthias; Feith, Marcus; Ebert, Matthias P; Friess, Helmut; Langer, Rupert; Höfler, Heinz; Zitzelsberger, Horst; Rosenberg, Robert; Walch, Axel (2012). Tumor classification of six common cancer types based on proteomic profiling by MALDI imaging. Journal of proteome research, 11(3), pp. 1996-2003. Washington, D.C.: American Chemical Society 10.1021/pr200784p

Lottaz, Daniel; Maurer, Christoph A; Noël, Agnès; Blacher, Silvia; Huguenin, Maya; Nievergelt, Alexandra; Niggli, Verena; Kern, Alexander; Müller, Stefan; Seibold, Frank; Friess, Helmut; Becker-Pauly, Christoph; Stöcker, Walter; Sterchi, Erwin E (2011). Enhanced activity of meprin-?, a pro-migratory and pro-angiogenic protease, in colorectal cancer. PLoS ONE, 6(11), e26450. Lawrence, Kans.: Public Library of Science 10.1371/journal.pone.0026450

Künzli, Beat M; Bernlochner, Maria-Isabell; Rath, Stephan; Käser, Samuel; Csizmadia, Eva; Enjyoji, Keiichi; Cowan, Peter; d'Apice, Anthony; Dwyer, Karen; Rosenberg, Robert; Perren, Aurel; Friess, Helmut; Maurer, Christoph A; Robson, Simon C (2011). Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancer. Purinergic signalling, 7(2), pp. 231-41. Dordrecht: Springer 10.1007/s11302-011-9228-9

Stickel, Felix; Osterreicher, Christoph H; Halangk, Juliane; Berg, Thomas; Homann, Nils; Hellerbrand, Claus; Patsenker, Eleonora; Schneider, Vreni; Kolb, Armin; Friess, Helmut; Schuppan, Detlef; Puhl, Gero; Seitz, Helmut K; Leathart, Julian L B; Day, Christopher P (2008). No role of matrixmetalloproteinase-3 genetic promoter polymorphism 1171 as a risk factor for cirrhosis in alcoholic liver disease. Alcoholism: clinical and experimental research, 32(6), pp. 959-65. Oxford: Wiley-Blackwell 10.1111/j.1530-0277.2008.00654.x

Popov, Yury; Patsenker, Eleonora; Stickel, Felix; Zaks, Jessica; Bhaskar, K Ramakrishnan; Niedobitek, Gerald; Kolb, Armin; Friess, Helmut; Schuppan, Detlef (2008). Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies. Journal of hepatology, 48(3), pp. 453-64. Amsterdam: Elsevier 10.1016/j.jhep.2007.11.021

Michalski, Christoph W; Shi, Xin; Reiser, Carolin; Fachinger, Patrick; Zimmermann, Arthur; Büchler, Markus W; Di Sebastiano, Pierluigi; Friess, Helmut (2007). Neurokinin-2 receptor levels correlate with intensity, frequency, and duration of pain in chronic pancreatitis. Annals of surgery, 246(5), pp. 786-93. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/SLA.0b013e318070d56e

Wildi, Stefan; Kleeff, Jörg; Mayerle, Julia; Zimmermann, Arthur; Böttinger, Erwin P; Wakefield, Lalage; Büchler, Markus W; Friess, Helmut; Korc, Murray (2007). Suppression of transforming growth factor beta signalling aborts caerulein induced pancreatitis and eliminates restricted stimulation at high caerulein concentrations. Gut, 56(5), pp. 685-92. London: BMJ Publishing Group 10.1136/gut.2006.105833

Osterreicher, Christoph H; Schultheiss, Jürgen; Wehler, Markus; Homann, Nils; Hellerbrand, Claus; Künzli, Beat; Friess, Helmut; Seitz, Helmut K; Stickel, Felix (2007). Genetic polymorphisms of manganese-superoxide dismutase and glutathione-S-transferase in chronic alcoholic pancreatitis. Mutagenesis, 22(5), pp. 305-10. Oxford: Oxford University Press 10.1093/mutage/gem017

Michalski, Christoph W; Autschbach, Frank; Selvaggi, Federico; Shi, Xin; Di Mola, Fabio Francesco; Roggo, Antoine; Müller, Michael W; Di Sebastiano, Pierluigi; Büchler, Markus W; Giese, Thomas; Friess, Helmut (2007). Increase in substance P precursor mRNA in noninflamed small-bowel sections in patients with Crohn's disease. American journal of surgery, 193(4), pp. 476-81. Amsterdam: Elsevier Science 10.1016/j.amjsurg.2006.08.075

Witt, Heiko; Sahin-Tóth, Miklós; Landt, Olfert; Chen, Jian-Min; Kähne, Thilo; Drenth, Joost Ph; Kukor, Zoltán; Szepessy, Edit; Halangk, Walter; Dahm, Stefan; Rohde, Klaus; Schulz, Hans-Ulrich; Le Maréchal, Cédric; Akar, Nejat; Ammann, Rudolf W; Truninger, Kaspar; Bargetzi, Mario; Bhatia, Eesh; Castellani, Carlo; Cavestro, Giulia Martina; ... (2006). A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis. Nature genetics, 38(6), pp. 668-73. New York, N.Y.: Nature America 10.1038/ng1797

Kleeff, J.; Friess, Helmut; Büchler, Markus Wolfgang (2001). Eingeladener Kommentar zu: „Der prognostische Wert der p53-Immunhistochemie beim Gallenblasenkarzinom“. Acta Chirurgica Austriaca, 33(2), pp. 96-98. Springer-Verlag 10.1007/BF02949577

Z’Graggen, K.; Friess, Helmut; Wagner, Markus; Büchler, Markus Wolfgang (1999). The pT4-carcinoma of the pancreas: Surgical and multimodal treatment. Acta Chirurgica Austriaca, 31(1), pp. 17-21. Springer-Verlag 10.1007/BF02619871

Friess, Helmut; Büchler, Markus W; Mueller, Christoph; Malfertheiner, Peter (1998). Immunopathogenesis of chronic pancreatitis. Gastroenterology, 115(4), pp. 1018-1022. Elsevier 10.1016/s0016-5085(98)70278-1

Maurer, Christoph A; Friess, Helmut; Kretschmann, Bodo; Wildi, Stefan; Müller, Christoph; Graber, Hans; Schilling, Martin; Büchler, Markus W (1998). Over-expression of ICAM-1, VCAM-1 and ELAM-1 might influence tumor progression in colorectal cancer. International journal of cancer, 79(1), pp. 76-81. Wiley-Blackwell 10.1002/(sici)1097-0215(19980220)79:1<76::aid-ijc15>3.0.co;2-f

Friess, Helmut; Kleeff, Jörg; Malfertheiner, Peter; Müller, Michael W.; Homuth, Kaiken; Büchler, Markus W. (1998). Influence of high-dose pancreatic enzyme treatment on pancreatic function in healthy volunteers. International journal of pancreatology, 23(2), pp. 115-124. Humana Press 10.1385/IJGC:23:2:115

Maurer, Christoph A.; Borner, Markus M.; Läuffer, Jörg; Friess, Helmut; Z'Graggen, Kaspar; Triller, Jürgen; Büchler, Markus W. (1998). Celiac axis infusion chemotherapy in advanced nonresectable pancreatic cancer. International journal of pancreatology, 23(3), pp. 181-186. Humana Press 10.1007/BF02788395

Hunger, Robert E; Mueller, Christoph; Z'graggen, Kaspar; Friess, Helmut; Büchler, Markus W (1997). Cytotoxic cells are activated in cellular infiltrates of alcoholic chronic pancreatitis. Gastroenterology, 112(5), pp. 1656-1663. Elsevier 10.1016/s0016-5085(97)70048-9

Friess, Helmut; Gassmann, Michael; Büchler, Markus W. (1997). Adjuvant therapy of pancreatic cancer using monoclonal antibodies and immune response modifiers. International journal of pancreatology, 21(1), pp. 43-52. Humana Press 10.1007/BF02785919

Friess, Helmut; Berberat, P.; Büchler, Markus Wolfgang (1997). Molecular alterations in pancreatic cancer. Acta Chirurgica Austriaca, 29(5), pp. 245-247. Springer-Verlag 10.1007/BF02621314

This list was generated on Sat Dec 21 19:05:24 2024 CET.
Provide Feedback